• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶对C1灭活剂的抑制作用。

C1 inactivator inhibition by plasmin.

作者信息

Harpel P C

出版信息

J Clin Invest. 1970 Mar;49(3):568-75. doi: 10.1172/JCI106267.

DOI:10.1172/JCI106267
PMID:4244455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC322505/
Abstract

Plasmin incubated with partially purified C[unk] inactivator produced a decrease in inhibitory activity which was related to the time of incubation and to the concentration of plasmin. This effect of plasmin was not influenced by the purity of the inhibitor preparations. Soybean trypsin inhibitor and tosyl arginine methyl ester (TAMe), substances which block the active enzymic center of plasmin, prevented the plasmin-induced inactivation. Double diffusion analysis of the functionally deficient, plasmin-treated C[unk] inactivator using a specific antibody, showed a reaction of identity with the untreated inhibitor. Agarose and acrylamide gel immunoelectrophoresis of a plasmin, inhibitor mixture showed the appearance of an additional precipitin band with immunologic reactivity similar to that of the untreated inhibitor. These results demonstrate that plasmin alters both the functional and immunoelectrophoretic properties of C[unk] inactivator, and that the active proteolytic site of plasmin is necessary for this interaction. Since C[unk] inactivator has been shown to inhibit several different proteolytic enzymes including C[unk], kallikrein, PF/Dil, and plasmin, this investigation provides a theoretical relationship between the fibrinolytic, kallikrein, and complement systems which may have pathophysiologic relevance to various human disease states.

摘要

与部分纯化的C[未知]灭活剂一起孵育的纤溶酶导致抑制活性降低,这种降低与孵育时间和纤溶酶浓度有关。纤溶酶的这种作用不受抑制剂制剂纯度的影响。大豆胰蛋白酶抑制剂和甲苯磺酰精氨酸甲酯(TAMe),这些阻断纤溶酶活性酶中心的物质,可防止纤溶酶诱导的失活。使用特异性抗体对功能缺陷的、经纤溶酶处理的C[未知]灭活剂进行双向扩散分析,结果显示与未处理的抑制剂具有同一性反应。纤溶酶与抑制剂混合物的琼脂糖和丙烯酰胺凝胶免疫电泳显示出现了一条额外的沉淀带,其免疫反应性与未处理的抑制剂相似。这些结果表明,纤溶酶改变了C[未知]灭活剂的功能和免疫电泳特性,并且纤溶酶的活性蛋白水解位点对于这种相互作用是必需的。由于已证明C[未知]灭活剂可抑制几种不同的蛋白水解酶,包括C[未知]、激肽释放酶、PF/稀释剂和纤溶酶,因此本研究提供了纤溶系统、激肽释放酶系统和补体系统之间的理论关系,这可能与各种人类疾病状态具有病理生理学相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94a4/322505/cf64cac42ba8/jcinvest00219-0164-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94a4/322505/a13ba060f560/jcinvest00219-0163-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94a4/322505/3c3a2aaf8db1/jcinvest00219-0164-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94a4/322505/d47fda3740ea/jcinvest00219-0164-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94a4/322505/cf64cac42ba8/jcinvest00219-0164-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94a4/322505/a13ba060f560/jcinvest00219-0163-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94a4/322505/3c3a2aaf8db1/jcinvest00219-0164-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94a4/322505/d47fda3740ea/jcinvest00219-0164-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94a4/322505/cf64cac42ba8/jcinvest00219-0164-c.jpg

相似文献

1
C1 inactivator inhibition by plasmin.纤溶酶对C1灭活剂的抑制作用。
J Clin Invest. 1970 Mar;49(3):568-75. doi: 10.1172/JCI106267.
2
Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.人血浆C1灭活剂与酶相互作用的研究。I. 与C1s、纤溶酶和胰蛋白酶的相互作用机制。
J Clin Invest. 1975 Mar;55(3):593-604. doi: 10.1172/JCI107967.
3
Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.人血浆α2-巨球蛋白。一种血浆激肽释放酶抑制剂。
J Exp Med. 1970 Aug 1;132(2):329-52. doi: 10.1084/jem.132.2.329.
4
Plasma inhibitors of the components of the fibrinolytic pathway in man.人纤维蛋白溶解途径成分的血浆抑制剂。
J Clin Invest. 1973 Jun;52(6):1394-401. doi: 10.1172/JCI107312.
5
New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.C1r、C1酯酶、凝血酶、纤溶酶、激肽释放酶和胰蛋白酶的新型合成抑制剂。
Biochim Biophys Acta. 1981 Oct 13;661(2):342-5. doi: 10.1016/0005-2744(81)90023-1.
6
Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase.胰蛋白酶、纤溶酶、激肽释放酶、凝血酶、C1r和C1酯酶的合成抑制剂。
Biochim Biophys Acta. 1977 Oct 13;484(2):417-22. doi: 10.1016/0005-2744(77)90097-3.
7
Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.血浆α2-巨球蛋白(激肽释放酶抑制剂)对血浆凝血活酶前体与激肽释放酶的分离作用
J Clin Invest. 1971 Oct;50(10):2084-90. doi: 10.1172/JCI106702.
8
Inhibitory effects of -amino acid esters on trypsin, plasmin, plasma kallikrein and thrombin.α-氨基酸酯对胰蛋白酶、纤溶酶、血浆激肽释放酶和凝血酶的抑制作用。
Biochim Biophys Acta. 1971 Jul 21;242(1):203-8. doi: 10.1016/0005-2744(71)90100-8.
9
The inactivator of the first component of human complement (C1INA): the complex formation with plasmin.人补体第一成分灭活剂(C1INA):与纤溶酶的复合物形成
Int Arch Allergy Appl Immunol. 1976;50(1):1-13. doi: 10.1159/000231475.
10
Degradation of human fibrinogen by plasms alpha2-macroglobulin-enzyme complexes.血浆α2-巨球蛋白-酶复合物对人纤维蛋白原的降解作用。
J Clin Invest. 1973 Sep;52(9):2175-84. doi: 10.1172/JCI107402.

引用本文的文献

1
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.遗传性和获得性血管性水肿:问题与进展:第三届C1酯酶抑制剂缺乏症研讨会及后续会议论文集
J Allergy Clin Immunol. 2004 Sep;114(3 Suppl):S51-131. doi: 10.1016/j.jaci.2004.06.047.
2
Relationships among the complement, kinin, coagulation, and fibrinolytic systems.补体、激肽、凝血和纤溶系统之间的关系。
Springer Semin Immunopathol. 1983;6(2-3):231-58. doi: 10.1007/BF00205875.
3
Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.

本文引用的文献

1
INHIBITION OF beta HEMOLYTIC STREPTOCOCCI FIBRINOLYSIN BY TRYPSIN INHIBITOR (ANTIPROTEASE).蛋白酶抑制剂(抗蛋白酶)对β-溶血性链球菌纤溶酶的抑制作用。
Science. 1944 Sep 1;100(2592):198-200. doi: 10.1126/science.100.2592.198.
2
Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein.遗传性血管性水肿。II. 血清球蛋白通透性因子和/或血浆激肽释放酶抑制剂缺乏。
J Allergy. 1962 Jul-Aug;33:330-41. doi: 10.1016/0021-8707(62)90032-1.
3
Proactivator function of human plasmin as shown by lysine esterase assay.
血浆α2-巨球蛋白(激肽释放酶抑制剂)对血浆凝血活酶前体与激肽释放酶的分离作用
J Clin Invest. 1971 Oct;50(10):2084-90. doi: 10.1172/JCI106702.
4
Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure.人血浆α2-巨球蛋白与酶相互作用的研究。亚基链结构蛋白水解修饰的证据。
J Exp Med. 1973 Sep 1;138(3):508-21. doi: 10.1084/jem.138.3.508.
5
Inhibitors of kallikrein in human plasma.人血浆中激肽释放酶的抑制剂
J Clin Invest. 1972 Jul;51(7):1611-23. doi: 10.1172/jci106962.
6
Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.人血浆α2-巨球蛋白。一种血浆激肽释放酶抑制剂。
J Exp Med. 1970 Aug 1;132(2):329-52. doi: 10.1084/jem.132.2.329.
7
Inflammatory sequences in acute pulmonary radiation injury.急性肺辐射损伤中的炎症序列。
Am J Pathol. 1976 Mar;82(3):549-72.
8
Studies on the nature of heat-labile anti-complementary activity in normal human serum.正常人血清中热不稳定抗补体活性的性质研究。
Clin Exp Immunol. 1979 Aug;37(2):310-22.
9
Inhibition of the classical and alternative pathways by amino acids and their derivatives.氨基酸及其衍生物对经典途径和替代途径的抑制作用。
Immunology. 1978 Mar;34(3):509-15.
10
Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin.人血浆C1灭活剂与酶相互作用的研究。I. 与C1s、纤溶酶和胰蛋白酶的相互作用机制。
J Clin Invest. 1975 Mar;55(3):593-604. doi: 10.1172/JCI107967.
通过赖氨酸酯酶测定显示的人纤溶酶的前激活剂功能。
J Biol Chem. 1961 Oct;236:2807-12.
4
Assay and properties of serum inhibitor of C'l-esterase.C1酯酶血清抑制剂的测定与特性
Proc Soc Exp Biol Med. 1959 Aug-Sep;101:608-11. doi: 10.3181/00379727-101-25034.
5
GEL FILTRATION OF PROTEINS, WITH PARTICULAR REFERENCE TO THE GLYCOPROTEIN, LUTEINIZING HORMONE.蛋白质的凝胶过滤,特别涉及糖蛋白促黄体激素
Anal Biochem. 1965 Aug;12:296-302. doi: 10.1016/0003-2697(65)90094-1.
6
HEREDITARY ANGIONEUROTIC EDEMA: TWO GENETIC VARIANTS.遗传性血管性水肿:两种基因变异体。
Science. 1965 May 14;148(3672):957-8. doi: 10.1126/science.148.3672.957.
7
SOME BIOCHEMICAL AND PHYSICAL PROPERTIES OF THE HUMAN PERMEABILITY GLOBULINS.人通透性球蛋白的一些生化和物理特性
Br J Exp Pathol. 1964 Dec;45(6):604-11.
8
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.圆盘电泳。II. 方法及其在人血清蛋白中的应用。
Ann N Y Acad Sci. 1964 Dec 28;121:404-27. doi: 10.1111/j.1749-6632.1964.tb14213.x.
9
ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE.补体在遗传性血管性水肿中的作用:C1酯酶的角色。
J Clin Invest. 1964 Nov;43(11):2204-13. doi: 10.1172/JCI105094.
10
LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN TISSUES.组织中纤维蛋白溶解活性的定位
Br Med Bull. 1964 Sep;20:210-2. doi: 10.1093/oxfordjournals.bmb.a070333.